Decision-making impairment + Fenfluramine
Fenfluramine is known to produce decision-making impairment, a cognitive effect. Reduced ability to evaluate risks, weigh options, and make sound judgments, particularly insidious because the individual often cannot recognize their own impairment.
About Decision-making impairment
Decision-making impairment during psychoactive substance use refers to a diminished capacity to engage in the cognitive processes required for sound judgment: identifying options, evaluating risks and benefits, anticipating consequences, integrating past experience, and selecting an appropriate course of action. This effect is arguably one of the most dangerous consequences of substance use because it undermines the very cognitive faculties needed to recognize and respond to danger.
The neuroscience of decision-making involves a distributed network of brain regions, with the ventromedial prefrontal cortex (vmPFC), orbitofrontal cortex (OFC), and anterior cingulate cortex (ACC) playing central roles. The vmPFC integrates emotional and factual information to assign value to potential outcomes. The OFC processes reward expectations and updates them based on outcomes. The ACC monitors for conflicts between competing options and signals when additional cognitive resources are needed. Substances that impair any of these regions or their connections degrade decision-making quality.
Alcohol is perhaps the most thoroughly studied decision-making impairment agent. At blood alcohol concentrations as low as 0.05%, measurable deficits in risk assessment, response inhibition, and outcome evaluation emerge. The combination of disinhibition (reduced behavioral restraint) with impaired risk assessment is particularly dangerous -- the individual is both more likely to consider risky options and less able to accurately evaluate their danger. This is why alcohol is so strongly associated with accidents, violence, and risky sexual behavior.
Benzodiazepines produce decision-making impairment through GABAergic suppression of prefrontal function, combined with anterograde amnesia that prevents the individual from learning from recent experiences within the same intoxication episode. Dissociatives impair decision-making through NMDA receptor blockade in prefrontal circuits, combined with the dissociation from consequence awareness that is inherent to the dissociative state. Psychedelics at high doses impair conventional decision-making by dissolving the stable self-model that normally anchors value judgments, though the decisions made in this state are sometimes experienced as profoundly meaningful rather than impaired.
A critical feature of decision-making impairment is the anosognosia-like quality it often assumes: the impaired individual frequently lacks insight into their own impairment. They feel that they are thinking clearly and making good decisions, even as their actual decision-making quality deteriorates dramatically. This is why harm reduction strategies should be established before substance use rather than relied upon during the experience, and why a sober companion or trip-sitter serves such an important protective function.